Bulletin
Investor Alert

Gilead Sciences Inc.

NAS: GILD

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

May 26, 2023, 7:48 p.m.

/zigman2/quotes/210293917/composite

$

77.10

Change

+0.0100 +0.01%

Volume

Volume 689,095

Quotes are delayed by 20 min

/zigman2/quotes/210293917/composite

Previous close

$ 77.65

$ 77.09

Change

-0.56 -0.72%

Day low

Day high

$77.01

$78.62

Open

52 week low

52 week high

$57.17

$89.74

Open

Insider Actions for Gilead Sciences Inc.

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
05/03/2023 Kevin E. Lofton
Director
1,887   Award at $0 per share. 0
05/03/2023 Jacqueline K. Barton
Director
1,887   Award at $0 per share. 0
05/03/2023 Harish M. Manwani
Director
1,887   Award at $0 per share. 0
05/03/2023 Javier J. Rodriguez
Director
1,887   Award at $0 per share. 0
05/03/2023 Anthony Welters
Director
1,887   Award at $0 per share. 0
05/03/2023 Sandra J. Horning
Director
1,887   Award at $0 per share. 0
05/03/2023 Harish M. Manwani
Director
368   Derivative/Non-derivative trans. at $79.45 per share. 29,237
05/01/2023 Kevin E. Lofton
Director
12,868   Gift at $0 per share. 0
03/13/2023 Merdad V. Parsey
Chief Medical Officer
6,126   Disposition at $78.99 per share. 483,892
03/10/2023 Daniel P. O'Day
Chairman & CEO; Director
14,017   Derivative/Non-derivative trans. at $79.5 per share. 1,114,351
03/10/2023 Andrew D. Dickinson
Chief Financial Officer
4,849   Derivative/Non-derivative trans. at $79.5 per share. 385,495
03/10/2023 Johanna Mercier
Chief Commercial Officer
5,116   Derivative/Non-derivative trans. at $79.5 per share. 406,722
03/10/2023 Merdad V. Parsey
Chief Medical Officer
5,328   Derivative/Non-derivative trans. at $79.5 per share. 423,576
03/10/2023 Sandra K. Patterson
SVP, Controllership
801   Derivative/Non-derivative trans. at $79.5 per share. 63,679
03/10/2023 Daniel P. O'Day
Chairman & CEO; Director
10,800   Derivative/Non-derivative trans. at $0 per share. 0
03/10/2023 Daniel P. O'Day
Chairman & CEO; Director
19,488   Derivative/Non-derivative trans. at $0 per share. 0
03/10/2023 Andrew D. Dickinson
Chief Financial Officer
7,394   Derivative/Non-derivative trans. at $0 per share. 0
03/10/2023 Andrew D. Dickinson
Chief Financial Officer
3,025   Derivative/Non-derivative trans. at $0 per share. 0
03/10/2023 Johanna Mercier
Chief Commercial Officer
7,951   Derivative/Non-derivative trans. at $0 per share. 0
03/10/2023 Johanna Mercier
Chief Commercial Officer
3,025   Derivative/Non-derivative trans. at $0 per share. 0
03/10/2023 Merdad V. Parsey
Chief Medical Officer
7,999   Derivative/Non-derivative trans. at $0 per share. 0
03/10/2023 Merdad V. Parsey
Chief Medical Officer
3,455   Derivative/Non-derivative trans. at $0 per share. 0
03/10/2023 Sandra K. Patterson
SVP, Controllership
1,320   Derivative/Non-derivative trans. at $0 per share. 0
03/10/2023 Sandra K. Patterson
SVP, Controllership
1,601   Derivative/Non-derivative trans. at $0 per share. 0
03/09/2023 Kevin E. Lofton
Director
8,442   Derivative/Non-derivative trans. at $52.38 per share. 442,191
03/01/2023 Daniel P. O'Day
Chairman & CEO; Director
4,842   Derivative/Non-derivative trans. at $79.59 per share. 385,374
03/01/2023 Merdad V. Parsey
Chief Medical Officer
12,984   Disposition at $79.96 per share. 1,038,200
03/01/2023 Daniel P. O'Day
Chairman & CEO; Director
11,362   Derivative/Non-derivative trans. at $0 per share. 0
02/15/2023 Andrew D. Dickinson
Chief Financial Officer
376   Award at $56.38 per share. 21,198
02/15/2023 Merdad V. Parsey
Chief Medical Officer
376   Award at $56.38 per share. 21,198
02/15/2023 Deborah H. Telman
EVP, Corporate Affairs & GC
376   Award at $56.38 per share. 21,198
02/06/2023 Andrew D. Dickinson
Chief Financial Officer
531   Derivative/Non-derivative trans. at $86.36 per share. 45,857
02/06/2023 Diane E. Wilfong
SVP, Controller & CAO
565   Derivative/Non-derivative trans. at $86.36 per share. 48,793
02/06/2023 Andrew D. Dickinson
Chief Financial Officer
1,817   Derivative/Non-derivative trans. at $0 per share. 0
02/06/2023 Diane E. Wilfong
SVP, Controller & CAO
1,864   Derivative/Non-derivative trans. at $0 per share. 0
01/24/2023 Daniel P. O'Day
Chairman & CEO; Director
59,078   Derivative/Non-derivative trans. at $84.02 per share. 4,963,733
01/24/2023 Andrew D. Dickinson
Chief Financial Officer
15,327   Derivative/Non-derivative trans. at $84.02 per share. 1,287,774
01/24/2023 Johanna Mercier
Chief Commercial Officer
15,325   Derivative/Non-derivative trans. at $84.02 per share. 1,287,606
01/24/2023 Merdad V. Parsey
Chief Medical Officer
17,749   Derivative/Non-derivative trans. at $84.02 per share. 1,491,270
01/24/2023 Diane E. Wilfong
SVP, Controller & CAO
1,244   Derivative/Non-derivative trans. at $84.02 per share. 104,520
01/24/2023 Daniel P. O'Day
Chairman & CEO; Director
136,647   Award at $0 per share. 0
01/24/2023 Daniel P. O'Day
Chairman & CEO; Director
78,370   Award at $0 per share. 0
01/24/2023 Andrew D. Dickinson
Chief Financial Officer
38,270   Award at $0 per share. 0
01/24/2023 Andrew D. Dickinson
Chief Financial Officer
27,932   Award at $0 per share. 0
01/24/2023 Johanna Mercier
Chief Commercial Officer
38,270   Award at $0 per share. 0
01/24/2023 Johanna Mercier
Chief Commercial Officer
29,124   Award at $0 per share. 0
01/24/2023 Merdad V. Parsey
Chief Medical Officer
43,715   Award at $0 per share. 0
01/24/2023 Merdad V. Parsey
Chief Medical Officer
29,644   Award at $0 per share. 0
01/24/2023 Diane E. Wilfong
SVP, Controller & CAO
4,100   Award at $0 per share. 0
01/24/2023 Diane E. Wilfong
SVP, Controller & CAO
1,784   Award at $0 per share. 0
12/30/2022 Merdad V. Parsey
Chief Medical Officer
553   Disposition at $85.33 per share. 47,187

Transaction Summary

Total insider purchases and sales reported to the SEC

Timeframe Transactions Shares
Last 3 months
18 Purchases
10 Sales
97,184
67,299
Last 6 months
38 Purchases
23 Sales
536,523
180,791
Last 12 months
56 Purchases
40 Sales
593,964
218,827

Officers and Executives

Mr. Daniel P. O'Day
Chairman & Chief Executive Officer
Mr. Andrew D. Dickinson
Chief Financial Officer
Dr. Merdad V. Parsey
Chief Medical Officer
Dr. Flavius Martin
Executive Vice President-Research
Ms. Johanna Mercier
Chief Commercial Officer
Dr. Tomas Cihlar
Vice President-Virology
Dr. Linda Slanec Higgins
Senior VP-Research & External Innovation
Dr. Mark Genovese
Senior Vice President-Inflammation Development
Ms. Janet Dorling
Senior VP-Global Commercial Product Strategy
Dr. William Grossman
Senior VP-Oncology Clinical Development
Dr. Adam Levy
Executive Director-Investor Relations
Mr. Dustin Haines
Vice President & General Manager-Asia 5
Mr. Joydeep Ganguly
Senior Vice President-Corporate Operations
Dr. Stacey Y. Ma
EVP-Pharmaceutical Development & Manufacturing
Ms. Melissa Grigorieff Koomey
Vice President-Global Commercial Operations
Ms. Sandra K. Patterson
SVP, Chief Accounting Officer & Controller
Ms. Jacquie Ross
Head-Investor Relations
Ms. Jyoti K. Mehra
Executive Vice President-Human Resources
Ms. Deborah H. Telman
Secretary, EVP-Corporate Affairs & General Counsel
Dr. Sandra J. Horning
Independent Director
Mr. Javier J. Rodriguez
Independent Director
Mr. Anthony Welters
Independent Director
Dr. Jeffrey A. Bluestone
Independent Director
Mr. Kevin E. Lofton
Lead Independent Director
Ms. Kelly A. Kramer
Independent Director
Dr. Jacqueline K. Barton
Independent Director
Mr. Harish M. Manwani
Independent Director
Link to MarketWatch's Slice.